Clinical Trial Update: Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of PB-119 in Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PB-119 (PB-119)

Snippet

Sponsor: PegBio Co., Ltd. | Conditions: Type II Diabetes Mellitus | Phase 1 | Status: COMPLETED